Zidovudine
Product Images NDC 53104-0105

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zidovudine (NDC 53104-0105). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

E94ab1eb 51f3 4cb0 A4de F3b93d3943b7 01

Chemical structure diagram of zidovudine, showing its molecular components with labeled atoms and bonds, including the azido group attached to the sugar moiety.*

FDA Label Image

E94ab1eb 51f3 4cb0 A4de F3b93d3943b7 02

Label for Zidovudine Syrup with a strength of 50 mg per 5 mL oral solution in a 240 mL bottle. The label states the active ingredient Zidovudine USP 50 mg per 5 mL, with Sodium Benzoate 0.2% as a preservative. It includes storage instructions and a note to pharmacists regarding dosing syringes. Manufactured by Cipla Ltd., Indore SEZ, India. The label also shows the product NDC 53104-0105.*

FDA Label Image

E94ab1eb 51f3 4cb0 A4de F3b93d3943b7 03

Zidovudine Syrup 50 mg/5 mL oral solution in a 240 mL bottle carton from Cipla Ltd. Label shows the active ingredient strength, usage instructions for oral use, storage conditions, pharmacist note on dosing accuracy in neonates, and manufacturer details including Cipla Ltd. in Indore SEZ, India. The NDC 53104-0105 is displayed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.